Showing results (231-240 of 337) with videos related to
Sort By:
Pageof 34
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|August 22, 2019
Progressive exercise training improves maximal aerobic capacity in individuals with well-healed burn injuriesSteven A Romero, Gilbert Moralez, Manall F Jaffery, et al.European Journal of Cancer (Oxford, England : 1990)|May 24, 2003
Trail-induced apoptosis and interaction with cytotoxic agents in soft tissue sarcoma cell linesS Tomek, W Koestler, P Horak, et al.Cancer|November 15, 1995
Results of combined modality therapy for patients with anal cancer (E7283). An Eastern Cooperative Oncology Group studyJ A Martenson, S R Lipsitz, M Lefkopoulou, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 9, 2011
Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancerDaniel G Haller, Josep Tabernero, Jean Maroun, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 2008
Oxaliplatin plus irinotecan compared with irinotecan alone as second-line treatment after single-agent fluoropyrimidine therapy for metastatic colorectal carcinomaDaniel G Haller, Mace L Rothenberg, Alfred O Wong, et al.Brain : a Journal of Neurology|November 6, 2008
Resistance training in patients with single, large-scale deletions of mitochondrial DNAJulie L Murphy, Emma L Blakely, Andrew M Schaefer, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2015
Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer: Final Results of the NO16968 Randomized Controlled Phase III TrialHans-Joachim Schmoll, Josep Tabernero, Jean Maroun, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2003
Safety and toxicity analysis of oxaliplatin combined with fluorouracil or as a single agent in patients with previously treated advanced colorectal cancerRamesh K Ramanathan, Jeffery W Clark, Nancy E Kemeny, et al.Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|February 1, 1993
Phase II multicenter evaluation of prolonged murine monoclonal antibody 17-1A therapy in pancreatic carcinomaL M Weiner, E Harvey, K Padavic-Shaller, et al.Clinical Colorectal Cancer|January 27, 2010
Current Opinion on Optimal Treatment Choices in First-line Therapy for Advanced or Metastatic Colorectal Cancer: Report From the Adelaide Colorectal Tumour Group Meeting; Stockholm, Sweden; September 2008Timothy J Price, Niall C Tebbutt, Christos S Karapetis, et al.Pageof 34